Skip to main content
. 2021 Feb 16;21:95. doi: 10.1186/s12872-021-01904-y

Table 2.

The details of medical managements grouped by NLR value < 4.8 and ≥ 4.8

Variable Overall Low NLR (< 4.8) High NLR (≥ 4.8) Standardized difference P value
Alpha-blockers 166 (76.9 %) 87 (77.7 %) 79 (76.0 %) 0.04 0.765
Beta-blockers 140 (64.8 %) 69 (61.6 %) 71 (68.3 %) 0.14 0.306
ARBs 78 (36.1 %) 43 (38.4 %) 35 (33.7 %) 0.1 0.469
ACEIs 32 (14.8 %) 15 (13.4 %) 17 (16.4 %) 0.08 0.542
CCBs 166 (76.9 %) 78 (69.6 %) 88 (84.6 %) 0.36 0.009
Statins 86 (39.8 %) 44 (39.3 %) 42 (40.4 %) 0.02 0.869

Values are n (%)

ARBs angiotensin II receptor blockers, ACEIs angiotensin-converting enzyme inhibitors, CCBs calcium-channel blockers, NLR neutrophil-to-lymphocyte ratio